{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:53:10Z","timestamp":1790751190385,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI13C0016"],"award-info":[{"award-number":["HI13C0016"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI15C1062"],"award-info":[{"award-number":["HI15C1062"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sj\u00f6gren\u2019s syndrome (SS) is an autoimmune disease mediated by lymphocytic infiltration into exocrine glands, resulting in progressive lacrimal and salivary destruction and dysfunctional glandular secretion. Metabolic syndrome influences the immune system. To investigate its relationship with metabolic abnormalities, we evaluated the pathogenesis of SS and the immune cell populations in non-obese diabetic NOD\/ShiLtJ mice with type 1 diabetes (T1D).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To induce metabolic abnormalities, streptozotocin (STZ)\u2014a glucosamine\u2013nitrosourea compound that destroys pancreatic \u03b2 cells, resulting in T1D\u2014was injected into NOD\/ShiLtJ mice. The blood glucose level was measured to evaluate induction of T1D. The severity of SS was assessed by determining the body weight, salivary flow rate, and histologic parameters. The expression levels of proinflammatory factors in the salivary glands, lacrimal gland, and spleen were quantified by real\u2013time PCR. The populations of various T\u2013 and B\u2013cell subtypes in the peripheral blood, spleen, and salivary glands were assessed by flow cytometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Induction of T1D in NOD\/ShiLtJ mice increased both the severity of SS and the levels of proinflammatory cytokines in the salivary glands compared to the controls. Furthermore, the number of interleukin-17\u2013producing immune cells in the peripheral blood, spleen, and salivary glands was increased in STZ- compared to vehicle-treated NOD\/ShiLtJ mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Metabolic abnormalities play an important role in the development of SS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-020-02343-7","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T15:03:07Z","timestamp":1588690987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Metabolic abnormalities exacerbate Sj\u00f6gren\u2019s syndrome by and is associated with increased the population of interleukin\u201317\u2013producing cells in NOD\/ShiLtJ mice"],"prefix":"10.1186","volume":"18","author":[{"given":"Sun-Hee","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sil","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SeungCheon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Ah","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JeongWon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ki","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-La","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"key":"2343_CR1","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zeron","year":"2016","unstructured":"Brito-Zeron P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, Sivils K, Theander E, Tzioufas A, Ramos-Casals M. Sjogren syndrome. Nat Rev Dis Primers. 2016;2:16047.","journal-title":"Nat Rev Dis Primers"},{"key":"2343_CR2","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.semarthrit.2006.08.007","volume":"36","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M, Brito-Zeron P, Font J. The overlap of Sjogren\u2019s syndrome with other systemic autoimmune diseases. Semin Arthritis Rheum. 2007;36:246\u201355.","journal-title":"Semin Arthritis Rheum"},{"key":"2343_CR3","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","volume":"42","author":"M Voulgarelis","year":"1999","unstructured":"Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjogren\u2019s syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren\u2019s syndrome. Arthritis Rheum. 1999;42:1765\u201372.","journal-title":"Arthritis Rheum"},{"key":"2343_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.molimm.2014.05.006","volume":"62","author":"JL Karnell","year":"2014","unstructured":"Karnell JL, Mahmoud TI, Herbst R, Ettinger R. Discerning the kinetics of autoimmune manifestations in a model of Sjogren\u2019s syndrome. Mol Immunol. 2014;62:277\u201382.","journal-title":"Mol Immunol"},{"key":"2343_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/154411130201300103","volume":"13","author":"S Cha","year":"2002","unstructured":"Cha S, Peck AB, Humphreys-Beher MG. Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: an update. Crit Rev Oral Biol Med. 2002;13:5\u201316.","journal-title":"Crit Rev Oral Biol Med"},{"issue":"Suppl 1","key":"2343_CR6","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/S0003-9969(99)90008-0","volume":"44","author":"MG Humphreys-Beher","year":"1999","unstructured":"Humphreys-Beher MG, Peck AB. New concepts for the development of autoimmune exocrinopathy derived from studies with the NOD mouse model. Arch Oral Biol. 1999;44(Suppl 1):S21\u20135.","journal-title":"Arch Oral Biol"},{"key":"2343_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1601-0825.2006.01241.x","volume":"12","author":"BM Lodde","year":"2006","unstructured":"Lodde BM, Mineshiba F, Kok MR, Wang J, Zheng C, Schmidt M, Cotrim AP, Kriete M, Tak PP, Baum BJ. NOD mouse model for Sjogren\u2019s syndrome: lack of longitudinal stability. Oral Dis. 2006;12:566\u201372.","journal-title":"Oral Dis"},{"key":"2343_CR8","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1002\/ar.23190","volume":"298","author":"EM Gervais","year":"2015","unstructured":"Gervais EM, Desantis KA, Pagendarm N, Nelson DA, Enger T, Skarstein K, Liaaen Jensen J, Larsen M. Changes in the submandibular salivary gland epithelial cell subpopulations during progression of Sjogren\u2019s syndrome-like disease in the NOD\/ShiLtJ mouse model. Anat Rec. 2015;298:1622\u201334.","journal-title":"Anat Rec"},{"key":"2343_CR9","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1002\/art.11311","volume":"48","author":"S Salomonsson","year":"2003","unstructured":"Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmstrom P, Wahren-Herlenius M, Jonsson R. Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren\u2019s syndrome. Arthritis Rheum. 2003;48:3187\u2013201.","journal-title":"Arthritis Rheum"},{"key":"2343_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1586\/1744666X.2014.891439","volume":"10","author":"FG Kroese","year":"2014","unstructured":"Kroese FG, Abdulahad WH, Haacke E, Bos NA, Vissink A, Bootsma H. B-cell hyperactivity in primary Sjogren\u2019s syndrome. Expert Rev Clin Immunol. 2014;10:483\u201399.","journal-title":"Expert Rev Clin Immunol"},{"key":"2343_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","volume":"34","author":"CG Vinuesa","year":"2016","unstructured":"Vinuesa CG, Linterman MA, Yu D, MacLennan IC. Follicular helper T cells. Annu Rev Immunol. 2016;34:335\u201368.","journal-title":"Annu Rev Immunol"},{"key":"2343_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3945\/an.115.010207","volume":"7","author":"CJ Andersen","year":"2016","unstructured":"Andersen CJ, Murphy KE, Fernandez ML. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016;7:66\u201375.","journal-title":"Adv Nutr"},{"key":"2343_CR13","first-page":"943162","volume":"2014","author":"J Kaur","year":"2014","unstructured":"Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:943162.","journal-title":"Cardiol Res Pract"},{"key":"2343_CR14","doi-asserted-by":"publisher","first-page":"393192","DOI":"10.1155\/2013\/393192","volume":"2013","author":"AA Bremer","year":"2013","unstructured":"Bremer AA, Jialal I. Adipose tissue dysfunction in nascent metabolic syndrome. J Obes. 2013;2013:393192.","journal-title":"J Obes"},{"key":"2343_CR15","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/icb.2016.77","volume":"94","author":"J Freitag","year":"2016","unstructured":"Freitag J, Berod L, Kamradt T, Sparwasser T. Immunometabolism and autoimmunity. Immunol Cell Biol. 2016;94:925\u201334.","journal-title":"Immunol Cell Biol"},{"key":"2343_CR16","first-page":"754","volume":"34","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M, Brito-Zeron P, Siso A, Vargas A, Ros E, Bove A, Belenguer R, Plaza J, Benavent J, Font J. High prevalence of serum metabolic alterations in primary Sjogren\u2019s syndrome: influence on clinical and immunological expression. J Rheumatol. 2007;34:754\u201361.","journal-title":"J Rheumatol"},{"key":"2343_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/0961203310367504","volume":"19","author":"M Perez-De-Lis","year":"2010","unstructured":"Perez-De-Lis M, Akasbi M, Siso A, Diez-Cascon P, Brito-Zeron P, Diaz-Lagares C, Ortiz J, Perez-Alvarez R, Ramos-Casals M, Coca A. Cardiovascular risk factors in primary Sjogren\u2019s syndrome: a case-control study in 624 patients. Lupus. 2010;19:941\u20138.","journal-title":"Lupus"},{"key":"2343_CR18","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10067-015-3072-1","volume":"35","author":"KL Augusto","year":"2016","unstructured":"Augusto KL, Bonfa E, Pereira RM, Bueno C, Leon EP, Viana VS, Pasoto SG. Metabolic syndrome in Sjogren\u2019s syndrome patients: a relevant concern for clinical monitoring. Clin Rheumatol. 2016;35:639\u201347.","journal-title":"Clin Rheumatol"},{"key":"2343_CR19","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00125-007-0886-7","volume":"51","author":"S Lenzen","year":"2008","unstructured":"Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008;51:216\u201326.","journal-title":"Diabetologia"},{"key":"2343_CR20","doi-asserted-by":"publisher","first-page":"12628","DOI":"10.1073\/pnas.0405099101","volume":"101","author":"GJ Shim","year":"2004","unstructured":"Shim GJ, Warner M, Kim HJ, Andersson S, Liu L, Ekman J, Imamov O, Jones ME, Simpson ER, Gustafsson JA. Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren\u2019s syndrome. Proc Natl Acad Sci USA. 2004;101:12628\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2343_CR21","doi-asserted-by":"publisher","first-page":"e3155","DOI":"10.7717\/peerj.3155","volume":"5","author":"X Han","year":"2017","unstructured":"Han X, Tao YL, Deng YP, Yu JW, Cai J, Ren GF, Sun YN, Jiang GJ. Metformin ameliorates insulitis in STZ-induced diabetic mice. PeerJ. 2017;5:e3155.","journal-title":"PeerJ"},{"key":"2343_CR22","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.2337\/db16-0480","volume":"65","author":"T Szasz","year":"2016","unstructured":"Szasz T, Wenceslau CF, Burgess B, Nunes KP, Webb RC. Toll-like receptor 4 activation contributes to diabetic bladder dysfunction in a murine model of Type 1 diabetes. Diabetes. 2016;65:3754\u201364.","journal-title":"Diabetes"},{"key":"2343_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1099\/mic.0.082610-0","volume":"161","author":"E Patterson","year":"2015","unstructured":"Patterson E, Marques TM, O\u2019Sullivan O, Fitzgerald P, Fitzgerald GF, Cotter PD, Dinan TG, Cryan JF, Stanton C, Ross RP. Streptozotocin-induced type-1-diabetes disease onset in Sprague-Dawley rats is associated with an altered intestinal microbiota composition and decreased diversity. Microbiology. 2015;161:182\u201393.","journal-title":"Microbiology"},{"key":"2343_CR24","first-page":"1219","volume":"32","author":"MA Gonzalez-Gay","year":"2005","unstructured":"Gonzalez-Gay MA, Gonzalez-Juanatey C, Pineiro A, Garcia-Porrua C, Testa A, Llorca J. High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol. 2005;32:1219\u201323.","journal-title":"J Rheumatol"},{"key":"2343_CR25","first-page":"15","volume":"9","author":"NA Sinicato","year":"2013","unstructured":"Sinicato NA, da Silva Cardoso PA, Appenzeller S. Risk factors in cardiovascular disease in systemic lupus erythematosus. Curr Cardiol Rev. 2013;9:15\u20139.","journal-title":"Curr Cardiol Rev"},{"key":"2343_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3109\/08916930903374527","volume":"43","author":"Y Sherer","year":"2010","unstructured":"Sherer Y, Zinger H, Shoenfeld Y. Atherosclerosis in systemic lupus erythematosus. Autoimmunity. 2010;43:98\u2013102.","journal-title":"Autoimmunity"},{"key":"2343_CR27","first-page":"435","volume":"32","author":"PH Dessein","year":"2005","unstructured":"Dessein PH, Joffe BI, Veller MG, Stevens BA, Tobias M, Reddi K, Stanwix AE. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol. 2005;32:435\u201342.","journal-title":"J Rheumatol"},{"key":"2343_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrd4518","volume":"14","author":"HS Bartlett","year":"2015","unstructured":"Bartlett HS, Million RP. Targeting the IL-17-T(H)17 pathway. Nat Rev Drug Discov. 2015;14:11\u20132.","journal-title":"Nat Rev Drug Discov"},{"key":"2343_CR29","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1002\/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4","volume":"44","author":"Y Katz","year":"2001","unstructured":"Katz Y, Nadiv O, Beer Y. Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a \u201cfine-tuning cytokine\u201d in inflammation processes. Arthritis Rheum. 2001;44:2176\u201384.","journal-title":"Arthritis Rheum"},{"key":"2343_CR30","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","volume":"25","author":"CT Weaver","year":"2007","unstructured":"Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007;25:821\u201352.","journal-title":"Annu Rev Immunol"},{"key":"2343_CR31","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.autrev.2014.08.022","volume":"13","author":"A Alunno","year":"2014","unstructured":"Alunno A, Carubbi F, Bartoloni E, Bistoni O, Caterbi S, Cipriani P, Giacomelli R, Gerli R. Unmasking the pathogenic role of IL-17 axis in primary Sjogren\u2019s syndrome: a new era for therapeutic targeting? Autoimmun Rev. 2014;13:1167\u201373.","journal-title":"Autoimmun Rev"},{"key":"2343_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235\u20138.","journal-title":"Nature"},{"key":"2343_CR33","doi-asserted-by":"publisher","first-page":"6038","DOI":"10.4049\/jimmunol.181.9.6038","volume":"181","author":"HY Wu","year":"2008","unstructured":"Wu HY, Quintana FJ, Weiner HL. Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4\u2009+\u2009CD25- LAP\u2009+\u2009regulatory T cell and is associated with down-regulation of IL-17\u2009+\u2009CD4\u2009+\u2009ICOS\u2009+\u2009CXCR5\u2009+\u2009follicular helper T cells. J Immunol. 2008;181:6038\u201350.","journal-title":"J Immunol"},{"key":"2343_CR34","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/ni.2569","volume":"14","author":"DA Bermejo","year":"2013","unstructured":"Bermejo DA, Jackson SW, Gorosito-Serran M, Acosta-Rodriguez EV, Amezcua-Vesely MC, Sather BD, Singh AK, Khim S, Mucci J, Liggitt D, et al. Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORgammat and Ahr that leads to IL-17 production by activated B cells. Nat Immunol. 2013;14:514\u201322.","journal-title":"Nat Immunol"},{"key":"2343_CR35","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/art.23214","volume":"58","author":"CQ Nguyen","year":"2008","unstructured":"Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren\u2019s syndrome: findings in humans and mice. Arthritis Rheum. 2008;58:734\u201343.","journal-title":"Arthritis Rheum"},{"key":"2343_CR36","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.4049\/jimmunol.181.4.2898","volume":"181","author":"A Sakai","year":"2008","unstructured":"Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren\u2019s syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol. 2008;181:2898\u2013906.","journal-title":"J Immunol"},{"key":"2343_CR37","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1136\/annrheumdis-2013-204584","volume":"74","author":"X Lin","year":"2015","unstructured":"Lin X, Rui K, Deng J, Tian J, Wang X, Wang S, Ko KH, Jiao Z, Chan VS, Lau CS, et al. Th17 cells play a critical role in the development of experimental Sjogren\u2019s syndrome. Ann Rheum Dis. 2015;74:1302\u201310.","journal-title":"Ann Rheum Dis"},{"key":"2343_CR38","first-page":"30","volume":"37","author":"LM del Lopez Valle","year":"2015","unstructured":"del Lopez Valle LM, Ocasio-Lopez C, Steffen M. Comparison of levels of salivary cytokines in diabetic and nondiabetic puerto rican children: a case-control pilot study. Pediatr Dent. 2015;37:30\u20134.","journal-title":"Pediatr Dent"},{"key":"2343_CR39","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.archoralbio.2017.08.001","volume":"83","author":"MM Azuma","year":"2017","unstructured":"Azuma MM, Gomes-Filho JE, Prieto AKC, Samuel RO, de Lima VMF, Sumida DH, Ervolino E, Cintra LTA. Diabetes increases interleukin-17 levels in periapical, hepatic, and renal tissues in rats. Arch Oral Biol. 2017;83:230\u20135.","journal-title":"Arch Oral Biol"},{"issue":"120\u2013128","key":"2343_CR40","first-page":"e124","volume":"22","author":"E Xiao","year":"2017","unstructured":"Xiao E, Mattos M, Vieira GHA, Chen S, Correa JD, Wu Y, Albiero ML, Bittinger K, Graves DT. Diabetes enhances IL-17 expression and alters the oral microbiome to increase its pathogenicity. Cell Host Microbe. 2017;22(120\u2013128):e124.","journal-title":"Cell Host Microbe"},{"key":"2343_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/imm.12512","volume":"146","author":"Z Tong","year":"2015","unstructured":"Tong Z, Liu W, Yan H, Dong C. Interleukin-17A deficiency ameliorates streptozotocin-induced diabetes. Immunology. 2015;146:339\u201346.","journal-title":"Immunology"},{"key":"2343_CR42","doi-asserted-by":"publisher","first-page":"11296","DOI":"10.1038\/srep11296","volume":"5","author":"X Sun","year":"2015","unstructured":"Sun X, Feng X, Tan W, Lin N, Hua M, Wei Y, Wang F, Li N, Zhang M. Adiponectin exacerbates collagen-induced arthritis via enhancing Th17 response and prompting RANKL expression. Sci Rep. 2015;5:11296.","journal-title":"Sci Rep"},{"key":"2343_CR43","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.celrep.2015.07.014","volume":"12","author":"Y Endo","year":"2015","unstructured":"Endo Y, Asou HK, Matsugae N, Hirahara K, Shinoda K, Tumes DJ, Tokuyama H, Yokote K, Nakayama T. Obesity drives Th17 cell differentiation by inducing the lipid metabolic kinase, ACC1. Cell Rep. 2015;12:1042\u201355.","journal-title":"Cell Rep"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02343-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-020-02343-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02343-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T19:14:57Z","timestamp":1620155697000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02343-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2343"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02343-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,5]]},"assertion":[{"value":"5 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animals: The procedures were approved by the Animal Research Ethics Committee of the Catholic University of Korea and conformed to the guidelines of the National Institutes of Health of the United States (Permit Number: CUMS- 2019-0001-01).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}